Understanding HIV’s genetic code will help treat patients with greater precision

A virus contains its own genes, but it is able to replicate only when it gets inside the cells of a host organism. A new study examines the genetic code of human immunodeficiency virus (HIV) to see how variations might determine the course of a patient’s infection. Researchers from Childrenโ€™s Hospital Los Angeles discovered a single difference in HIVโ€™s genetic code in two locations will alter the way the virus infects T-cells โ€” and so impact the severity of a patient’s symptoms.

For some time now, researchers have known that HIV targets CD4+ T-cells, a type of white blood cell that plays an important role in organizing the bodyโ€™s immune response to pathogens (such as invading viruses and bacteria). To enter these cells and then gradually infect the entire immune system, HIV exploits one of two different receptors on the surface of a personโ€™s T-cells: either CCR5 or CXCR4 โ€” usually referred to as R5 and X4, respectively.

While nearly every HIV infection uses the R5 “door” to enter T-cells, the virus, in about 50 percent of all patients, will suddenly switch and begin to use the X4 “door” instead.

Since antiretroviral drugs focus on the R5 receptor, this switch to X4 renders these drugs useless and so usually signals a worsening of a patientโ€™s symptoms.

The researchers of the current study, led by Dr. Grace Aldrovandi, chief of the hospitalโ€™s division of infectious diseases, took a closer look at the envelope that surrounds HIV. Once it comes into contact with host T-cells, thisย envelope gains and mingles with some material from the patientโ€™s host cell.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: The Genetics of Human Immunodeficiency Virus: Understanding How HIV Enters T-Cells

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Foodโ€”health harming industries or life-saving innovators?
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.โ€™s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-12-at-10.05.11-AM
Pro-vaccine โ€œheroโ€ vs. an anti-vax โ€œvillainโ€: โ€˜Bad Vaxxโ€™ video stirs MAHA backlash
ChatGPT Image May 12, 2026, 10_19_00 AM 2
Viewpointโ€” 'Muscular governance': How authoritarianism is surging corporate-linked energy misinformation
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challengingย 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.